Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in France / NCT07234604
Starting soon Observational

Is 3D Modeling From Non-contrast CT Accurate for Minimally Invasive Lung Segmentectomies ?

NCT07234604 · tracked via the Priya Life Science France tracker
Phase
Observational
Started
2025-12-01
Last updated
2025-11-24

Condition(s) studied

Lung CancerNon-Small Cell Lung Cancer

Investigational drug(s) / intervention(s)

Thoraco-abdomino-pelvic CT scan without and with contrast injection.

Thoraco-abdomino-pelvic CT scan without and with contrast injection.: Eligible patients undergo the usual preoperative procedure, including consultations and CT scan with and without contrast injection.

Study summary

To assess the RELIABILITY in terms of accuracy of 3D-CT and 2D-CT reconstructions compared to intraoperative data regarding bronchovascular anatomy and tumor location. 3D CT reconstruction (CT scan without contrast injection) with Innersight3D® is equivalent to 2D CT (CT scan with contrast injection) for planning a minimally invasive lung segmentectomy.

Evaluate the impact of 3D reconstruction (from a CT scan without injection of contrast agent) on intraoperative and postoperative results

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Adult patient ≥ 18 years * Patient agreeing to participate in the study * Patient with clinical stage IA lung lesions ≤ 2 cm in diameter AND a suspected or proven malignancy. * Chest CT scan available without and then with contrast * Eligible for VATS or RATS segmentectomy based on respiratory explorations Exclusion Criteria: * Patient refusal to participate in the study * Allergic reactions to radiographic contrast agents * History of ipsilateral cardiothoracic surgery * Open segmentectomy (thoracotomy) * Histology different from that of NSCLC * Inability to provide the subject with informed information (difficulty understanding the subject, insufficient command of French, etc.) * Pregnant or breastfeeding women * Severe cognitive impairment and/or suspicion of lack of compliance or adherence, in the investigator's judgment

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Service Chirurgie Thoracique - CHU de Strasbourg - France Strasbourg Strasbourg

More University Hospital, Strasbourg, France trials in France

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07234604 on ClinicalTrials.gov ↗ ← All trials in France